ECONOMIC IMPACT OF NEW FORMS OF ANTIMICROBIAL TREATMENT FOR NOSOCOMIAL PNEUMONIA IN CARDIOVASCULAR INTENSIVE CARE UNITS

摘要

Nosocomial pneumonia (NP) are those that appear 48 hours after hospital admission, and they are the sec-ond leading cause of infection in general wards and the first cause in intensive care units (ICUs) worldwide. Its incidence has been reported between 10-20, which can reach up to 20 in patients receiving artifi-cial mechanical ventilation, and its mortality exceeds 501-3; that is why they are considered diseases of high morbidity, mortality and socio-economic impact.Early empirical treatment with broad-spectrum an-timicrobial is the correct first step in order to reduce its mortality; however, this therapeutic potential may expose the patient to overdose of antibiotics, so de-escalation of these drugs is a strategy to replace them with a simple but effective therapy, after knowing the results of microbiological cultures and having a satis-factory clinical course4-8.